TherapeuticsMD (NASDAQ:TXMD) Earns Hold Rating from Analysts at StockNews.com

StockNews.com started coverage on shares of TherapeuticsMD (NASDAQ:TXMD – Free Report) in a research report sent to investors on Tuesday morning. The brokerage issued a hold rating on the stock. TherapeuticsMD Price Performance NASDAQ:TXMD opened at $1.85 on Tuesday. The company has a 50 day simple moving average of $2.02 and a two-hundred day simple […]

Leave a Reply

Your email address will not be published.

Previous post Analysts Set The Coca-Cola Company (NYSE:KO) Target Price at $68.55
Next post DA Davidson Reaffirms “Buy” Rating for WD-40 (NASDAQ:WDFC)